文献速递传染病防控与疫情报告免疫规划

泰国白喉疫情期间成人接种1剂、2剂和3剂系列破伤风-白喉类毒素减量疫苗(Td)后的血清保护率

Seroprotection rate in adults after 1-dose, 2-dose, and 3-dose series of a reduced-diphtheria-tetanus toxoid vaccine (Td) during a diphtheria outbreak in Thailand.
PubMed 文献 · Vaccine · 2020-01-24

在泰国白喉疫情期间,研究纳入160名医护人员和161名20-60岁成人,接种前测白喉抗毒素(DAT)水平,按4-8周和6-12个月间隔安排第2、3剂Td,每剂后4周测DAT。基线血清保护率为32.6%,接种1剂后升至87.1%(95%CI 83.4-90.8%),追加剂次后略升,30-49岁人群免疫应答最低。作者建议疫情期间成人接种1剂Td,1980年前出生者可考虑2剂系列。

要点

  • 基线血清保护率为32.6%,接种1剂Td后升至87.1%(95%CI 83.4-90.8%)。
  • 追加剂次后血清保护率仅略升,30-49岁人群免疫应答最低。
  • 作者建议疫情期间成人接种1剂Td,1980年前出生者可考虑2剂系列。

核心结论

  • 作者建议白喉疫情期间成人接种1剂Td,1980年前出生者可考虑2剂系列。

研究设计与样本

  • 研究纳入160名医护人员和161名20-60岁成人,接种前测白喉抗毒素(DAT)水平。
  • 按第2剂4-8周、第3剂6-12个月间隔安排Td,每剂后4周测DAT。
  • DAT≥0.1 IU/mL为血清保护,≥1 IU/mL为长期血清保护,达到长期保护者不再追加剂次。

主要发现

  • 基线血清保护率为32.6%,接种1剂后升至87.1%(95%CI 83.4-90.8%)。
  • 追加剂次后血清保护率仅略升。
  • 30-49岁人群免疫应答最低。

关键数值与推荐

  • DAT≥0.1 IU/mL判定为血清保护,≥1 IU/mL判定为长期血清保护。
  • 基线血清保护率32.6%,1剂后87.1%(95%CI 83.4-90.8%)。

临床怎么用

  • 作者建议白喉疫情期间成人接种1剂Td。
  • 作者建议1980年前出生者可考虑2剂系列。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To evaluate seroprotection of different dosing strategies of reduced-diphtheria-tetanus-toxoid vaccine (Td) for adults during a diphtheria outbreak in Thailand, we enrolled 160 healthcare workers and 161 adults aged 20-60 years old and measured diphtheria antitoxin (DAT) level before administration of a Td vaccine. We scheduled a second Td at 4-8 weeks and a third Td at 6-12 months interval. DAT was measured 4 weeks after each dose. DAT levels of ≥0.1 and ≥1 IU/mL were considered as seroprotective and long-term seroprotective. Persons achieving long-term seroprotection were not given a further dose. The baseline seroprotection rate was 32.6%, which increased to 87.1% (95% confidence interval, 83.4-90.8%) after one dose. The seroprotection rate increased slightly with additional doses. The immune response was lowest among persons 30-49 years of age. We suggest 1-dose Td for adults during a diphtheria outbreak, and a 2-dose series being considered for those born before 1980.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Suntarattiwong P, Vandepitte WP, Singhamatr P, et al. Seroprotection rate in adults after 1-dose, 2-dose, and 3-dose series of a reduced-diphtheria-tetanus toxoid vaccine (Td) during a diphtheria outbreak in Thailand. Vaccine. 2020. PMID: 31987691. doi:10.1016/j.vaccine.2020.01.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。